This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2025!
March 18-21, 2025San Diego Convention Center

Bert Frohlich, Ph.D.
Principal and Owner at Biopharm Designs, LLC
Speaker

Profile

Bert is a PhD biochemical engineer with over 30 years of experience in the biotechnology, pharmaceutical, and chemical industries. He started his own consulting company, Biopharm Designs LLC, in 2016, initially focused on bioprocess design and development for biopharmaceuticals. Due to his passion for the environment, he has migrated his practice towards the alternative protein space by applying his skills in fermentation and cell culture process development primarily, but also facility design and cost estimation. Although most of his leadership experience was in the biopharm CMC space, he served as Vice President of Engineering and Commercialization for BlueNalu Inc. and Ivy Farm Technologies, startup companies both targeting the emerging cultivated meat market. Since then, he has also advised several other alternative protein companies and is serving as CTO for pre-seed Akoya Technologies seeking to be a contract development and manufacturing organization.

Before becoming a consultant, he held director-level positions at Shire, Amgen, EMD and Acambis (now Sanofi) and worked as a senior engineer at Genzyme, Biometics and Roche in process/facility design, bioprocess development and manufacturing technical services. Over the course of his career, Bert introduced a variety of products to manufacturing through the scale up and tech transfer of cell culture and other processes. In addition to advising on strategic direction in process and manufacturing technology, he now also helps clients design and implement high-level business processes, including quality-by-design, towards improving work efficiency, costs, timelines, and product quality.

Agenda Sessions

  • Chairperson's Remarks - Progress Towards Commercialization in the Cultured Meat Industry

    1:25pm